ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 32 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $23,000 | -34.3% | 9,044 | -9.6% | 0.00% | – |
| Q2 2020 | $35,000 | -31.4% | 10,000 | 0.0% | 0.00% | – |
| Q1 2020 | $51,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q4 2019 | $51,000 | -19.0% | 10,000 | -50.0% | 0.00% | – |
| Q3 2019 | $63,000 | -11.3% | 20,000 | 0.0% | 0.00% | – |
| Q2 2019 | $71,000 | -1.4% | 20,000 | 0.0% | 0.00% | – |
| Q1 2019 | $72,000 | +20.0% | 20,000 | 0.0% | 0.00% | – |
| Q4 2018 | $60,000 | -38.1% | 20,000 | 0.0% | 0.00% | – |
| Q3 2018 | $97,000 | -34.9% | 20,000 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $149,000 | -17.2% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $180,000 | 0.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $180,000 | -9.1% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $198,000 | +7.6% | 20,000 | -33.3% | 0.00% | 0.0% |
| Q2 2017 | $184,000 | 0.0% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $184,000 | +1126.7% | 30,000 | +2900.0% | 0.00% | – |
| Q4 2013 | $15,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 781,292 | $2,039,172 | 1.87% |
| GSA CAPITAL PARTNERS LLP | 88,923 | $232 | 0.02% |
| Glass Jacobson Investment Advisors llc | 12,255 | $31,986 | 0.02% |
| Rathbones Group PLC | 289,803 | $756,386 | 0.01% |
| N.E.W. Advisory Services LLC | 12,960 | $33,826 | 0.01% |
| Virtu Financial LLC | 17,388 | $45 | 0.00% |
| BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $14,687 | 0.00% |
| ALGERT GLOBAL LLC | 14,680 | $38 | 0.00% |
| Close Asset Management Ltd | 11,400 | $30 | 0.00% |
| Altshuler Shaham Ltd | 12,847 | $33,408 | 0.00% |